Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065652
Filing Date
2025-05-07
Accepted
2025-05-07 16:09:31
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cprx-20250331.htm   iXBRL 10-Q 2019138
2 EX-31.1 cprx-ex31_1.htm EX-31.1 14555
3 EX-31.2 cprx-ex31_2.htm EX-31.2 14564
4 EX-32.1 cprx-ex32_1.htm EX-32.1 10956
5 EX-32.2 cprx-ex32_2.htm EX-32.2 10971
  Complete submission text file 0000950170-25-065652.txt   10298517

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cprx-20250331.xsd EX-101.SCH 1359556
95 EXTRACTED XBRL INSTANCE DOCUMENT cprx-20250331_htm.xml XML 2078793
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 25921405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)